Home › Burkitt Lymphoma › Rhode Island › Providence
Pag-aaral pangklinika para sa Burkitt Lymphoma sa Providence, RI
Isang pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Providence. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
- Rhode Island Hospital, Providence
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Nagre-recruitPhase 3
- Rhode Island Hospital, Providence
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Nagre-recruitPhase 2
- Rhode Island Hospital, Providence
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 1
- Lifespan Cancer Institute at Rhode Island Hospital, Providence
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
- Rhode Island Hospital, Providence
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Nagre-recruitPhase 3
- Rhode Island Hospital, Providence
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- Rhode Island Hospital, Providence
Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod
- Houston, TX21 pag-aaral
- Milwaukee, WI16 pag-aaral
- Philadelphia, PA16 pag-aaral
- New York City, NY14 pag-aaral
- Chicago, IL14 pag-aaral
- Cincinnati, OH12 pag-aaral
- Atlanta, GA12 pag-aaral
- Seattle, WA11 pag-aaral
- Durham, NC10 pag-aaral
- Boston, MA10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Aurora, CO10 pag-aaral
Iba pang pag-aaral sa Providence
- Kanser sa Ovary15 pag-aaral
- Kanser ng Endometrium14 pag-aaral
- Obesity14 pag-aaral
- Non-Small Cell Lung Cancer12 pag-aaral
- Kanser (lahat ng uri)12 pag-aaral
- Crohn's Disease12 pag-aaral
- Ulcerative Colitis11 pag-aaral
- Kanser sa Suso11 pag-aaral
- Acute Myeloid Leukemia10 pag-aaral
- Metastatic Cancer9 pag-aaral
- Overweight9 pag-aaral
- Sakit ni Alzheimer8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.